These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 15264268)

  • 1. Inherited predisposition to cancer: a historical overview.
    Lynch HT; Shaw TG; Lynch JF
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):5-22. PubMed ID: 15264268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
    Güran S; Ozet A; Dede M; Gille JJ; Yenen MC
    Cancer Genet Cytogenet; 2005 Jul; 160(2):164-8. PubMed ID: 15993273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary cancer in adults.
    Lynch HT; Fusaro RM; Lynch J
    Cancer Detect Prev; 1995; 19(3):219-33. PubMed ID: 7750110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
    Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
    Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.
    Lynch HT; Fusaro RM; Lynch JF
    Future Oncol; 2007 Apr; 3(2):169-81. PubMed ID: 17381417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of hereditary colon cancer.
    Rustgi AK
    Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
    Nagore E; Montoro A; García-Casado Z; Botella-Estrada R; Insa A; Lluch A; López-Guerrero JA; Guillén C
    Melanoma Res; 2009 Aug; 19(4):211-4. PubMed ID: 19571771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary common cancers: molecular and clinical genetics.
    Russo A; Zanna I; Tubiolo C; Migliavacca M; Bazan V; Latteri MA; Tomasino RM; Gebbia N
    Anticancer Res; 2000; 20(6C):4841-51. PubMed ID: 11205230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
    Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
    J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary ovarian cancer.
    Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.
    Cederquist K; Emanuelsson M; Wiklund F; Golovleva I; Palmqvist R; Grönberg H
    Clin Genet; 2005 Dec; 68(6):533-41. PubMed ID: 16283884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited cancer susceptibility syndromes in paediatric practice.
    Field M; Shanley S; Kirk J
    J Paediatr Child Health; 2007 Apr; 43(4):219-29. PubMed ID: 17444822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
    Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.